- Publication status:
- Publisher copy:
- Copyright date:
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record